Accepted for/Published in: Journal of Participatory Medicine
Date Submitted: Apr 19, 2024
Date Accepted: Nov 27, 2024
Advances in newborn screening: development of an online scenario-based tool to enable research participation and public engagement.
ABSTRACT
Background:
Newborn screening (NBS) aims to identify babies affected by rare but serious genetic conditions. As technology advances, there is the potential to expand the NBS programme following evaluation of the likely benefits and disbenefits. It is important to consider the family experience of screening, and the views of the public. To engage in public dialogue can be difficult; the conditions, screening processes, and associated moral and ethical considerations are complex. We consider a new approach to engage and consult on the implementation of extended genetic testing in NBS for Cystic Fibrosis.
Objective:
To develop a stand-alone online resource to enable a range of stakeholders to understand and consider the question: How/should extended genetic testing be used when screening babies for Cystic Fibrosis?
Methods:
Four development workshops with policy makers, parents, and other stakeholders informed the design of an interactive activity, including the structure, content, and questions posed. Vignettes constructed using interview data, and translated into scripts were recorded to provide short films to represent and provoke consideration of families’ experiences.
Results:
An open access online resource, ‘Cystic Fibrosis Newborn Screening: You Decide’, was developed and usability and acceptability tested to provide the ‘user’ (e.g. a parent, the general public, and/or a healthcare professional) with an interactive scenario-based presentation of the potential outcomes of extended genetic testing allowing them to visualize the impact upon families. A learning workbook explains key concepts and processes. The user is then presented with questions to collect their views on potential approaches to implementing extended genetic testing.
Conclusions:
The resulting tool facilitates public engagement and understanding of complex genetic and screening concepts. It intends to help people form considered views and facilitate access to the perspectives of parents and the wider public on genetic testing that are otherwise difficult to obtain but are of importance to healthcare professionals and policy makers. Clinical Trial: NCT06299566
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.